ICU Medical, based in San Clemente, California, announced it will purchase Pfizer’s infusion systems unit for $1 billion in cash and stock, according to a Bloomberg article. The deal will more than quadruple its annual sales.
ICU Medical makes disposable systems for IV therapy and had $342 million in revenue last year. Pfizer will become its biggest shareholder with 17 percent ownership, according Bloomberg data.
Read the full story